about
Acellular Urethra Bioscaffold: Decellularization of Whole Urethras for Tissue Engineering Applications.An appraisal of human mitochondrial DNA instability: new insights into the role of non-canonical DNA structures and sequence motifs.Human mesenchymal stem cell expression program upon extended ex-vivo cultivation, as revealed by 2-DE-based quantitative proteomics.Differentiation of human umbilical cord matrix mesenchymal stem cells into neural-like progenitor cells and maturation into an oligodendroglial-like lineage.Intracoronary Delivery of Human Mesenchymal/Stromal Stem Cells: Insights from Coronary Microcirculation Invasive Assessment in a Swine ModelSeparation technologies for stem cell bioprocessing.Stem cell bioengineering strategies to widen the therapeutic applications of haematopoietic stem/progenitor cells from umbilical cord blood.Bioreactor design for clinical-grade expansion of stem cells.Concise review: Genomic instability in human stem cells: current status and future challenges.Gelatin porous scaffolds fabricated using a modified gas foaming technique: characterisation and cytotoxicity assessment.Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells.Microcarrier expansion of mouse embryonic stem cell-derived neural stem cells in stirred bioreactors.Magnetoresistive chip cytometer.Different stages of pluripotency determine distinct patterns of proliferation, metabolism, and lineage commitment of embryonic stem cells under hypoxia.Kinetic and metabolic analysis of mouse embryonic stem cell expansion under serum-free conditions.Monitoring the ex-vivo expansion of human mesenchymal stem/stromal cells in xeno-free microcarrier-based reactor systems by MIR spectroscopy.Scaling up the ex vivo expansion of human circulating CD34(+)progenitor cells with upregulation of angiogenic and anti-inflammatory potential.Extracellular matrix microarrays to study inductive signaling for endoderm specification.Proliferation extent of CD34+ cells as a key parameter to maximize megakaryocytic differentiation of umbilical cord blood-derived hematopoietic stem/progenitor cells in a two-stage culture protocol.Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia.Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex vivo expansion using serum-/xeno-free culture media.Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells.Ex vivo expansion of cord blood haematopoietic stem/progenitor cells under physiological oxygen tensions: clear-cut effects on cell proliferation, differentiation and metabolism.Tridimensional configurations of human mesenchymal stem/stromal cells to enhance cell paracrine potential towards wound healing processes.Developing a co-culture system for effective megakaryo/thrombopoiesis from umbilical cord blood hematopoietic stem/progenitor cells.A Fully-Closed and Automated Hollow Fiber Bioreactor for Clinical-Grade Manufacturing of Human Mesenchymal Stem/Stromal Cells.Hematopoietic Niche - Exploring Biomimetic Cues to Improve the Functionality of Hematopoietic Stem/Progenitor Cells.Gene delivery to human bone marrow mesenchymal stem cells by microporation.Large-scale expansion of mouse embryonic stem cells on microcarriers.Initial CD34+ cell-enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon ex vivo expansion.Clinical-Grade Manufacturing of Therapeutic Human Mesenchymal Stem/Stromal Cells in Microcarrier-Based Culture Systems.Stirred tank bioreactor culture combined with serum-/xenogeneic-free culture medium enables an efficient expansion of umbilical cord-derived mesenchymal stem/stromal cells.Integrated culture platform based on a human platelet lysate supplement for the isolation and scalable manufacturing of umbilical cord matrix-derived mesenchymal stem/stromal cells.Scale-up of mouse embryonic stem cell expansion in stirred bioreactors.In vitro assessment of three dimensional dense chitosan-based structures to be used as bioabsorbable implants.A xeno-free microcarrier-based stirred culture system for the scalable expansion of human mesenchymal stem/stromal cells isolated from bone marrow and adipose tissue.Scalable ex vivo expansion of human mesenchymal stem/stromal cells in microcarrier-based stirred culture systems.Oxazoline-based antimicrobial oligomers: synthesis by CROP using supercritical CO2.Three-Dimensional Co-culture of Human Hematopoietic Stem/Progenitor Cells and Mesenchymal Stem/Stromal Cells in a Biomimetic Hematopoietic Niche Microenvironment
P50
Q30837590-01B1CC83-500F-4D8E-B285-7A0FF8E706BEQ34337096-FF857A5B-F217-4C47-99D3-3BE772A4F85AQ34391664-2F2C2A6E-D9D7-40D5-97F4-2C76A0A8D7B7Q34428273-9F51B5DF-878B-460A-906F-A88834440470Q35812317-DBB6E34B-269A-4E53-982C-B2C013185ACDQ38034154-986954D4-444E-41D4-A004-385C551063A8Q38097003-7FFEB2A1-8978-4BCA-BAAC-6C3F43608B43Q38102652-7603786C-CADC-4ED5-BC7D-1A5989557FA1Q38235527-74088DD1-837A-488B-8E0B-48CF8AC669DFQ38920928-824E0B81-B3A5-40AF-9D3B-17D63E0917F5Q38928264-25BF8634-A5B0-467D-926C-875E1CB5D7F9Q39491001-4E24CCF7-AE5F-4AC2-9ED0-9B5F2C5532EAQ39544508-E946F244-68FC-46B5-A9DF-6FCCFCF644B2Q39694788-C0806097-99EC-437A-89AE-AC8D01B6038CQ39808684-9FD14B39-9B7F-4E6E-9538-B33502506EC7Q40173940-49CB04D3-5237-4F74-BEF9-AE5ABF007EFCQ40421676-1294E3C9-578B-468D-8CA2-ED18A3E577CDQ41592312-59BE0598-9D62-4FF2-A0EA-3DEDB80D9336Q42210360-FE2BFAED-2267-49B3-B88B-75F106716673Q42636758-FC1E1F10-4541-40B7-B379-226FFE5B4979Q43216186-C06C9FA5-AC67-40A0-84ED-FEC062AA0BEFQ44297451-4437B849-2D9E-4FE0-B96C-CF314F64571AQ45855287-85E68A22-D66C-4E04-A5A0-8E7ABA17751AQ46079135-348FE8CE-AEB8-4EE1-8B7F-F4BAF0D65D52Q46419580-C78B9752-E622-4377-8192-02C1750E19E2Q47745481-5F336890-889F-4BA8-BAC7-D670A5BDB1AAQ48213538-2BA80480-A7A8-48E4-B1C3-BF6266FB5DEEQ48589365-A4633E31-739A-4BEE-AED3-2CA99CCBF5AEQ50534344-6DE2F4B9-FFD7-4EC8-883F-20E8C21592D4Q50659967-141F886A-579C-43D1-AE64-726A513400BBQ50685487-97435440-E0DE-43C0-9F05-A8875C719D2AQ51313343-AE7AC734-E16A-45A1-AB5A-22BC47AE6603Q51335986-24D2F8ED-1587-445C-AA35-217DF2D7BD12Q53063065-11B29C87-E801-4496-A49E-FA642CC4F67BQ53229865-79988C83-B95D-45AC-9895-9BBCA3CC3B2FQ53417523-CD527965-D1CE-4BE3-8093-EC691D401EE4Q53443164-6CB3ACBF-E81C-4DE4-B1B1-DCEA6AE47C7FQ53490878-20DB9D22-49CA-4ECA-B515-C650A9C56607Q54359269-E4F4B2F8-0E86-4982-B768-BD1A414BF9A4Q58111760-020ECEBF-11B6-4C59-B27D-DEEE53CBC8A5
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Cláudia Lobato da Silva
@en
Cláudia Lobato da Silva
@nl
type
label
Cláudia Lobato da Silva
@en
Cláudia Lobato da Silva
@nl
prefLabel
Cláudia Lobato da Silva
@en
Cláudia Lobato da Silva
@nl
P2038
Claudia_Silva9
P31
P496
0000-0002-1091-7651